NCT06672718View on ClinicalTrials.gov

A Study of SPY002-091 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

February 18, 2026

Study Completion Date

June 22, 2026

Conditions

Healthy

Interventions

DRUG

SPY002-091

Experimental

OTHER

Placebo

Placebo

Trial Locations (1)

90630

RECRUITING

Spyre Site 1, Cypress

All Listed Sponsors

collaborator

Altasciences Company Inc.

INDUSTRY

lead

Spyre Therapeutics, Inc.

INDUSTRY